BRIM Biotechnology Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
32
- Stock Symbol
-
6885
- Share Price
-
$0.75
- (As of Friday Closing)
BRIM Biotechnology General Information
Description
BRIM Biotechnology Inc is engaged in the research and development of new drug translation, genetic testing services, research and development services in natural and engineering sciences, and medical laboratory services. The Group has two reportable operating segments: BRIM's main business is new drug translational development services, and Compass's main business is gene sequencing and testing technology services. It generates the majority of its revenue from the BRIM segment. Geographically, it operates in Taiwan, Japan, and the USA. It generates the majority of its revenue from Taiwan.
Contact Information
Website
www.brimbiotech.comCorporate Office
- 8th Floor, No. 1, Alley 30
- Lane 358, Ruiguang Road, Neihu District
- Taipei, 114-92
- Taiwan
Corporate Office
- 8th Floor, No. 1, Alley 30
- Lane 358, Ruiguang Road, Neihu District
- Taipei, 114-92
- Taiwan
BRIM Biotechnology Stock Performance
As of 20-Nov-2026, BRIM Biotechnology’s stock price is $0.75. Its current market cap is $100M with 133M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.75 | $0.80 | $0.62 - $1.08 | $100M | 133M | 949K | -$0.11 |
BRIM Biotechnology Financials Summary
As of 30-Sep-2026, BRIM Biotechnology has a trailing 12-month revenue of $397K.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 105,525 | 88,746 | 79,482 | 89,381 |
| Revenue | 397 | 176 | 10 | 3 |
| EBITDA | (14,485) | (14,075) | (10,565) | (22,610) |
| Net Income | (13,947) | (13,991) | (9,831) | (22,089) |
| Total Assets | 49,713 | 58,444 | 73,307 | 57,884 |
| Total Debt | 243 | 510 | 236 | 117 |
BRIM Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BRIM Biotechnology Patents
BRIM Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4777077-A1 | Ophthalmic composition | Pending | 28-Aug-2023 | ||
| JP-2025532327-A | Composition containing pedf-derived short peptides and mesenchymal stem cells for bone and cartilage regeneration | Pending | 05-Oct-2022 | ||
| AU-2023356324-A1 | Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration | Pending | 05-Oct-2022 | ||
| EP-4598560-A1 | Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration | Pending | 05-Oct-2022 | ||
| EP-4598560-A4 | Compositions comprising pedf-derived short peptides and mesenchymal stem cells for bone/cartilage regeneration | Pending | 05-Oct-2022 | A61K38/55 |
BRIM Biotechnology Signals
BRIM Biotechnology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BRIM Biotechnology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
BRIM Biotechnology FAQs
-
When was BRIM Biotechnology founded?
BRIM Biotechnology was founded in 2013.
-
Where is BRIM Biotechnology headquartered?
BRIM Biotechnology is headquartered in Taipei, Taiwan.
-
What is the size of BRIM Biotechnology?
BRIM Biotechnology has 32 total employees.
-
What industry is BRIM Biotechnology in?
BRIM Biotechnology’s primary industry is Biotechnology.
-
Is BRIM Biotechnology a private or public company?
BRIM Biotechnology is a Public company.
-
What is BRIM Biotechnology’s stock symbol?
The ticker symbol for BRIM Biotechnology is 6885.
-
What is the current stock price of BRIM Biotechnology?
As of 20-Nov-2026 the stock price of BRIM Biotechnology is $0.75.
-
What is the current market cap of BRIM Biotechnology?
The current market capitalization of BRIM Biotechnology is $100M.
-
What is BRIM Biotechnology’s current revenue?
The trailing twelve month revenue for BRIM Biotechnology is $397K.
-
What is BRIM Biotechnology’s annual earnings per share (EPS)?
BRIM Biotechnology’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process